Expression of N-acetyl transferase human and human arrest defective 1 proteins in thyroid neoplasms

被引:34
作者
Arnesen, T
Gromyko, D
Horvli, O
Fluge, O
Lillehaug, J
Varhaug, JE
机构
[1] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway
[2] Univ Bergen, Dept Surg Sci, N-5020 Bergen, Norway
[3] Haukeland Hosp, N-5021 Bergen, Norway
[4] Haukeland Univ Hosp, Dept Oncol, N-5021 Bergen, Norway
关键词
D O I
10.1089/thy.2005.15.1131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein acetylation is an important posttranslational modification regulating oncogenesis, apoptosis and cell cycle. NATH (N-acetyl transferase human) is overexpressed at the mRNA level in papillary thyroid carcinomas relative to non-neoplastic thyroid tissue. The NATH protein has recently been demonstrated to be the partner of hARD1 (human Arrest defective 1) and this complex acetylates the N-termini of proteins. ARD1 has also been implicated in the destabilization of the transcription factor HIF-1 alpha (hypoxia inducible factor-1 alpha). Using human thyroid papillary carcinoma biopsies and NATH- and hARD1-specific antibodies, we examined the levels of endogenous NATH and hARD1 proteins in 27 patients. We demonstrate that NATH protein level is upregulated in neoplastic versus non-neoplastic tissue in good accordance with our previous mRNA findings. In all tumors in which NATH was downregulated compared to non-neoplastic tissue, the hARD1 protein level was concomitantly reduced. SiRNA-mediated knockdown of NATH resulted in decreased levels of hARD1 protein. Taken together, these results suggest that NATH positively affects the level of hARD1 protein both in vivo and in cell cultures.
引用
收藏
页码:1131 / 1136
页数:6
相关论文
共 20 条
[1]   Identification and characterization of the human ARD1-NATH protein acetyltransferase complex [J].
Arnesen, T ;
Anderson, D ;
Baldersheim, C ;
Lanotte, M ;
Varhaug, JE ;
Lillehaug, JR .
BIOCHEMICAL JOURNAL, 2005, 386 :433-443
[2]   Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines [J].
Baldini, E ;
Toller, M ;
Graziano, FM ;
Russo, FP ;
Pepe, M ;
Biordi, L ;
Marchioni, E ;
Curcio, F ;
Ulisse, S ;
Ambesi-Impiombato, FS ;
D'Armiento, M .
THYROID, 2004, 14 (11) :881-888
[3]   DISTRIBUTION OF THE 72-KD TYPE-IV COLLAGENASE IN NONNEOPLASTIC AND NEOPLASTIC THYROID-TISSUE [J].
CAMPO, E ;
MERINO, MJ ;
LIOTTA, L ;
NEUMANN, R ;
STETLERSTEVENSON, W .
HUMAN PATHOLOGY, 1992, 23 (12) :1395-1401
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   Acetylation of proteins as novel target for antitumor therapy: Review article [J].
Di Gennaro, E ;
Bruzzese, F ;
Caraglia, M ;
Abruzzese, A ;
Budillon, A .
AMINO ACIDS, 2004, 26 (04) :435-441
[6]   THE MECHANISM OF N-TERMINAL ACETYLATION OF PROTEINS [J].
DRIESSEN, HPC ;
DEJONG, WW ;
TESSER, GI ;
BLOEMENDAL, H .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1985, 18 (04) :281-325
[7]   NATH, a novel gene overexpressed in papillary thyroid carcinomas [J].
Fluge, O ;
Bruland, O ;
Akslen, LA ;
Varhaug, JE ;
Lillehaug, JR .
ONCOGENE, 2002, 21 (33) :5056-5068
[8]   Difference in patterns of met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue [J].
Fluge, O ;
Haugen, DRF ;
Lillehaug, JR ;
Varhaug, JE .
WORLD JOURNAL OF SURGERY, 2001, 25 (05) :623-631
[9]  
FLUGE O, 2005, UNPUB THYROID
[10]   Regulation and destabilization of HIF-1α by ARD1-mediated acetylation [J].
Jeong, JW ;
Bae, MK ;
Ahn, MY ;
Kim, SH ;
Sohn, TK ;
Bae, MH ;
Yoo, MA ;
Song, EJ ;
Lee, KJ ;
Kim, KW .
CELL, 2002, 111 (05) :709-720